The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals

Molecular and Cellular Biology

Volumn 20, Issue 12, 2000, Pages 4309-4319

  Chang, David W ^a   Claassen, Gisela F ^b   Hann, Stephen R ^b   Cole, Michael D ^a  

^a PRINCETON UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; SOMATOMEDIN C;

APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; GENE MUTATION; GENETIC TRANSFORMATION; HUMAN; HUMAN CELL; MISSENSE MUTATION; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSACTIVATION;

ANIMALS; APOPTOSIS; BURKITT LYMPHOMA; CELL DIVISION; CELL LINE; GENE EXPRESSION REGULATION; GENES, MYC; HUMANS; MUTATION, MISSENSE; TRANSFECTION;

EID: 0034037132     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.12.4309-4319.2000     Document Type: Article

References (63)

1. Albert, T., B. Urlbauer, F. Kohlhuber, B. Hammersen, and D. Eick. 1994. Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines. Oncogene 9:759-763.
2. Alverez, E., I. Northwood, F. Gonzalez, D. Latour, A. Seth, C. Abate, T. Curran, and R. Davis. 1991. Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. Characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase. J. Biol. Chem. 266:15277-15285.
3. Askew, D. S., R. A. Ashimin, B. C. Simmons, and J. L. Cleveland. 1991. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915-1922.
4. Beijersbergen, R. L., E. M. Humans, L. Zhu, and R. Bernards. 1994. Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation. EMBO J. 13:4080-4086.
5. Bhatia, K., K. Huppi, G. Spangler, D. Siwarski, R. Iyer, and I. Magrath. 1993. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat. Genet. 5:56-61.
6. Bhatia, K., G. Spangler, G. Gaidano, N. Haindy, R. Dalla-Favera, and I. Magrath. 1994. Mutations in the coding region of c-myc occur frequently in acquired immunodeficiency syndrome-associated lymphomas. Blood 84:883-888.
7. Bissonnette, R. P., F. Echeverri, A. Mahboubi, and D. R. Green. 1993. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 359:552-554.
8. Brennscheidt, U., D. Eick, R. Kunzmann, U. Martens, M. Kiehntopf. R. Mertelsmann, and F. Herrmann. 1994. Burkitt-like mutations in the c-myc gene locus in prolymphocytic leukemia. Leukemia 8:897-902.
9. Brough, D. E., T. J. Hofmann, K. B. Ellwood, R. A. Townley, and M. D. Cole. 1995. An essential domain of the c-Myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation. Mol. Cell. Biol. 15:1536-1544.
10. Bush, A., M. Mateyak, K. Dugan, A. Obaya, S. Adiachi, J. Sedivy, and M. D. Cole. 1998. c-myc null cells misregulate cad and gadd45 but not other proposed c-myc targets. Genes Dev. 12:3797-3802.
11. Claassen, G., and S. Hann. 1999. Myc-mediated transformation: the repression connection. Oncogene 18:2925-2933.
12. Clark, H. M., T. Yano, T. Otsuki. E. S. Jaffe, D. Shibata, and M. Raffeld. 1994. Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas. Cancer Res. 54:3383-3386.
13. Cole, M. D., and S. B. McMahon. 1999. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18:2916-2924.
14. Dang, C. V. 1999. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19:1-11.
15. Eischen, C. M., J. D. Weber, M. F. Roussel, C. J. Sherr, and J. L. Cleveland. 1999. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 13:2658-2669.
16. Evan, G., and T. D. Littlewood. 1993. The role of c-myc in cell growth. Curr. Opin. Genet. Dev. 3:44-49.
17. Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Penn, and D. C. Hancock. 1992. Induction of apoptosis in fibrohlasts by c-myc protein. Cell 69:119-128.
18. Fanidi, A., E. A. Harrington, and G. I. Evan. 1992. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359:554-556.
19. Franke, T. F., D. R. Kaplan, and L. C. Cantley. 1997. P13K: downstream AKTion blocks apoptosis. Cell 88:435-437.
20. Frykberg, L., T. Graf, and B. Vennstrom. 1987. The transforming activity of the chicken c-myc gene can be potentiated by mutations. Oncogene 1:415-421.
21. Galaktionov, K., X. Chen, and D. Beach, 1996. CDC25 cell-cycle phosphatase as a target of c-myc. Nature 382:511-517.
22. Green, D., and J. Reed. 1998. Mitochondria and apoptosis. Science 281: 1309-1312.
23. Gu, W., K. Bhatia, I. T. Magrath, C. V. Dang, and R. Dalla-Favera. 1994. Binding and suppression of the Myc transcriptional activation domain by p107. Science 264:251-254.
24. Harrington, E. A., M. R. Bennett, A. Fanidi, and G. I. Evan. 1994. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13:3286-3295.
25. Henriksson, M, A. Bakardjiev, G. Klein, and B. Luscher. 1993. Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential. Oncogene 8:3199-3209.
26. Hoang, A. T., B. Lutterbach, B. C. Lewis, T. Yano, T.-Y. Chou, J. F. Barrett, M. Raffeld, S. R. Hann, and C. V. Dang. 1995. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain. Mol. Cell. Biol. 15:4031-4042.
27. Jacobs, J. J., B. Scheuen, J. W. Voncken, K. Kieboom, A. Berns, and M. van Lohuizen. 1999. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 13:2678-2690.
28. Johnston, J. M., M. T. Yu, and W. L. Carroll. 1991. c-myc hypermutation is ongoing in endemic, but not all Burkitt's lymphoma. Blood 78:2419-2425.
29. Juin, P., A. O. Hueber, T. Littlewood, and G. I. Evan. 1999. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev. 13:1367-1381.
30. Kauffmann-Zeh, A., P. Rodriguez-Viciana, E. Ulrich, C. Gilbert, P. Coffer, J. Downward, and G. Evan. 1997. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385:544-548.
31. Kennedy, S. G., E. S. Kandel, T. K. Cross, and N. Hay. 1999. Akt/protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol. Cell. Biol. 19:5800-5810.
32. Kennedy, S. G., A. J. Wagner, S. D. Conzen, J. Jordan, A. Bellacosa, P. N. Tsichlis, and N. Hay. 1997. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 11:701-713.
33. Kunkel, T. A., K. Bebenek, and J. McClary. 1991. Efficient site-directed mutagenesis using uracil-containing DNA. Methods Enzymol. 204:125-139.
34. Land, H., L. F. Parada, and R. A. Weinberg. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least 2 cooperating oncogenes. Nature 384:596-602.
35. Lee, C., and E. Reddy. 1999. The v-myc oncogene. Oncogene 18:2997-3003.
36. Lutterbach, B., and S. R. Hann. 1999. c-Myc transactivation domain-associated kinases: questionable role for map kinases in c-Myc phosphorylation. J. Cell. Biochem. 72:483-491.
37. Lutterbach, B., and S. R. Hann. 1994. Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol. Cell. Biol. 14:5510-5522.
38. Lutterbach, B., and S. R. Hann. 1997. Overexpression of c-Myc and cell immortalization alters c-Myc phosphorylation. Oncogene 14:967-975.
39. Marhin, W. W., S. Chen, L. M. Facchini, A. J. J. Fornace, and L. Z. Penn. 1997. Myc represses the growth arrest gene gadd45. Oncogene 14:2825-2834.
40. Mateyak, M. K., A. J. Obaya, S. Adachi, and J. M. Sedivy. 1997. Phenotypes of Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ. 8:1039-1048.
41. McDonnell, T. J., and S. J. Korsmeyer. 1991. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 349:254-256.
42. McMahon, S. B., H. A. Van Buskirk, K. A. Dugan, T. D. Copeland, and M. D. Cole. 1998. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94:363-374.
43. Miller, A. D., D. Miller, J. V. Garcia, and C. Lynch. 1993. Use of retroviral vectors for gene transfer and expression. Methods Enzymol. 217:581-599.
44. Noguchi, K., C. Kitanaka, H. Vamana, A. Kokubu, T. Mochizuki, and Y. Kuchino. 1999. Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase. J. Biol. Chem. 274:32580-32587.
45. Packham, G., and J. L. Cleveland. 1994. Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol. Cell. Biol. 14:5741-5747.
46. Packham, G., C. W. Porter, and J. L. Cleveland. 1996. c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways. Oncogene 13:461-469.
47. Penn, L. J. Z., M. W. Brooks, E. M. Laufer, and H. Land. 1990. Negative autoregulation of c-myc transcription. EMBO J. 9:1113-1122.
48. Prendergast, G. 1999. Mechanisms of apoptosis by c-Myc. Oncogene 18: 2967-87.
49. Pulverer, B. J., C. Fisher, K. Vousden, T. Littlewood, G. Evan, and J. R. Woodgett. 1994. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene 9:59-70.
50. Salghetti, S. E., S. Kim, and W. P. Tansey. 1999. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J. 18:717-726.
51. Schmitt, C. A., M. E. McCurrach, E. de Stanchina, R. R. Wallace-Brodeur, and S. W. Lowe. 1999. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev. 13:2670-2677.
52. Sears, R., G. Leone, J. DeGregori, and J. Nevins. 1999. Ras enhances Myc protein stability. Mol. Cell 3:169-179.
53. Shim, H., Y. S. Chun, B. C. Lewis, and C. V. Dang. 1998. A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc. Natl. Acad. Sci. USA 95:1511-1516.
54. Shim, H., C. Dolde, B. C. Lewis, C. S. Wu, G. Dang, R. A. Jungmann, R. Dalla-Favera, and C. V. Dang. 1997. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. USA 94: 6658-6663.
55. Smith-Sorensen, B., E. M. Hijmans, R. L. Begersbergen, and R. Bernards. 1996. Functional analysis of Burkitt's lymphoma mutant c-Myc proteins. J. Biol. Chem. 271:5513-5518.
56. Spotts, G. D., S. V. Patel, Q. Xiao, and S. R. Hann. 1997. Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins. Mol. Cell. Biol. 17:1459-1468.
57. Stone, J., L. T. De, G. Ramsay, E. Jakobovits, J. M. Bishop, H. Varmus, and W. Lee. 1987. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7:1697-1709.
58. Symonds, G., A. Hartshorn, A. Kennewell, M. O'Mara, A. Bruskin, and M. Bishop. 1989. Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential. Oncogene 4:285-294.
59. wat1/cip1. Genes Dev. 8:2817-2830.
60. Wagner, A. J., M. B. Small, and N. Hay. 1993. Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2. Mol. Cell. Biol. 13:2432-3440.
61. Wu, M., M. Arsura, R. E. Bellas, M. J. FitzGerald, H. Lee, S. L. Schauer. D. H. Sherr, and G. E. Sonnenshein. 1996. Inhibition of c-myc expression induces apoptosis of WEHI-231 murine B cells. Mol. Cell. Biol. 16:5015-5025.
62. Xiao, Q., G. Claassen, J. Shi, S. Adachi, J. Sedivy, and S. R. Hann. 1998. Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis. Genes Dev. 12:3803-3808.
63. Yano, T., C. A. Sander, H. M. Clark, M. V. Dolezal, E. S. Jaffe, and M. Raffeld. 1993. Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma. Oncogene 8:2741-2748.